Investor Relations (IR) Questions: Pain Therapeutics Inc PTIE
Click here to return to the biotech IRQ Index
Answers received: August 2013
1) When is the last time PTIE raised cash through an offering (diluted)? No change from below.
2) How much cash (not cash equivalents) does PTIE have? $52.8 MM as of 6/30/13.
3) What and approximately when is the next known catalyst? We expect Pfizer will provide info regarding their plans for REMOXY in the fall of this year.
4) What is PTIE's quarterly cash burn? We've said our cash usage in 2013 will be less than $10mm.
5) Does PTIE have an existing line of credit and if so how much can they draw against it? Still no.
1) When is the last time PTIE raised cash through an offering (diluted)? No change from below.
2) How much cash (not cash equivalents) does PTIE have? $52.8 MM as of 6/30/13.
3) What and approximately when is the next known catalyst? We expect Pfizer will provide info regarding their plans for REMOXY in the fall of this year.
4) What is PTIE's quarterly cash burn? We've said our cash usage in 2013 will be less than $10mm.
5) Does PTIE have an existing line of credit and if so how much can they draw against it? Still no.
Answers received: January 2013
1) When is the last time PTIE raised cash through an offering (diluted)?
Other than stock issued via our 1998 Equity Incentive Plan, the last cash we raised via stock sale was in 2004.
2) How much cash (not cash equivalents) does PTIE have?
Cash, cash, equivalents and short term investments at 9/30/12 totaled $92.5 million. In December 2012 we returned $34 million to stockholders in a nondividend distribution.
3) What and approximately when is the next known catalyst?
Regarding REMOXY, Pfizer has announced plans to meet with the FDA in March 2013.
4) What is PTIE's quarterly cash burn?
Over the first nine months of 2012, cash, cash equivalents and short term investments decreased by $5.6 million.
5) Does PTIE have an existing line of credit and if so how much can they draw against it?
We don’t have a line of credit.
Best regards,
Pete Roddy
Vice President and CFO
1) When is the last time PTIE raised cash through an offering (diluted)?
Other than stock issued via our 1998 Equity Incentive Plan, the last cash we raised via stock sale was in 2004.
2) How much cash (not cash equivalents) does PTIE have?
Cash, cash, equivalents and short term investments at 9/30/12 totaled $92.5 million. In December 2012 we returned $34 million to stockholders in a nondividend distribution.
3) What and approximately when is the next known catalyst?
Regarding REMOXY, Pfizer has announced plans to meet with the FDA in March 2013.
4) What is PTIE's quarterly cash burn?
Over the first nine months of 2012, cash, cash equivalents and short term investments decreased by $5.6 million.
5) Does PTIE have an existing line of credit and if so how much can they draw against it?
We don’t have a line of credit.
Best regards,
Pete Roddy
Vice President and CFO
